Physician profile
Jonathan I Meyer
NPI 1265481725
$1,772.78
in general payments reported to CMS, 2019-2025
11 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $32.34 · 2021: $93.95 · 2022: $795 · 2023: $121 · 2024: $305 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $366.34 | 2022 | |
| Abbott Laboratories | $354.21 | 2021-2025 | Navitor, Esprit, Diamondback Peripheral |
| Cardiovascular Systems INC. | $324.22 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.56 | 2022-2024 | Jardiance |
| Boston Scientific Corporation | $132.65 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $131.61 | 2019 | |
| Philips North America LLC | $92.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $86.68 | 2020-2023 | Xarelto |
| Neurocrine Biosciences, INC. | $51.48 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $34.59 | 2023 | Verquvo |
| Abiomed | $22.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.